The Patent Finder

Egen, Inc.

Also on record
Records under this name other than patents Egen, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Egen, Inc.

PatentTitleStatus Expires Confidence
US 7,964,571Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,144,546Nucleic acid-lipopolymer compositions
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,827,331Nucleic acid-lipopolymer compositions
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,900,621Polyamine derivatives
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,932,638Polyamine Derivatives
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 9,254,334Polyamine derivatives
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,569,065Compositions and methods for the delivery of biologically active RNAs
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,460,696Polyamine derivatives
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,468,687Immuno gene therapy for treatment of cancer and hyperproliferative diseases
Formerly held
Term ended
Term ended Feb 7, 2026 · From the USPTO record
Term endedTerm ended Feb 7, 2026From the USPTO record
US 8,623,837Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases
Formerly held
Term ended
Term ended Dec 24, 2025 · From the USPTO record
Term endedTerm ended Dec 24, 2025From the USPTO record
10 of 20 patents shown.
Pro members see all 20.
Pro members: see all 20 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited